Ameritas Investment Partners, Inc. Guardant Health, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.84 Billion
- Q2 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 11,263 shares of GH stock, worth $257,697. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,263
Previous 11,693
3.68%
Holding current value
$257,697
Previous $241,000
34.85%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding GH
# of Institutions
331Shares Held
116MCall Options Held
680KPut Options Held
1.66M-
Vanguard Group Inc Valley Forge, PA11.6MShares$266 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$257 Million0.01% of portfolio
-
Baillie Gifford & CO6.09MShares$139 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$103 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$102 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.34B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...